Charles River Laboratories International Inc. (CRL) has demonstrated improving relative strength within the Favored Green Zone. The shares currently hold an SIA SMAX score of 10 out of 10 and rank second out of 504 securities in the SIA S&P 500 Index Report. Charles River has advanced nine positions over the past month and 282 positions over the past quarter.
The Drugs sector is also positioned in the Favored Green Zone of the SIA Sector Report, ranking second out of 31 sectors.
Charles River’s most recent Point and Figure signal is a Double Top. Initial resistance is located near the psychological $300 level at $300.36, followed by additional resistance at $351.92 and the previous high of $464.35. On a pullback, near-term support is located at the 3-box reversal level of $272.05, with further support at $214.51.
The shares have gained 32.15% over the past month, 80.20% over the past quarter and 82.32% over the past year. By comparison, the S&P 500 Index has returned 4.29%, 2.80% and 19.28%, respectively, over the same periods.
Charles River Laboratories International provides products and services supporting pharmaceutical and biotechnology companies, government agencies and academic institutions in their research and drug-development activities. Its Research Models and Services segment includes Research Models, Research Model Services and Cell Solutions, which provide foundational tools used in the discovery of new molecules.
Disclaimer: SIACharts Inc. specifically represents that it does not give investment advice or advocate the purchase or sale of any security or investment whatsoever. This information has been prepared without regard to any particular investors investment objectives, financial situation, and needs. None of the information contained in this document constitutes an offer to sell or the solicitation of an offer to buy any security or other investment or an offer to provide investment services of any kind. As such, advisors and their clients should not act on any recommendation (express or implied) or information in this report without obtaining specific advice in relation to their accounts and should not rely on information herein as the primary basis for their investment decisions. Information contained herein is based on data obtained from recognized statistical services, issuer reports or communications, or other sources, believed to be reliable. SIACharts Inc. nor its third party content providers make any representations or warranties or take any responsibility as to the accuracy or completeness of any recommendation or information contained herein and shall not be liable for any errors, inaccuracies or delays in content, or for any actions taken in reliance thereon. Any statements nonfactual in nature constitute only current opinions, which are subject to change without notice.
